Literature DB >> 7596997

Relationship between the phasic period of interdigestive migrating contraction and the systemic bioavailability of acetaminophen in dogs.

K Sagara1, H Mizuta, M Ohshiko, M Shibata, K Haga.   

Abstract

The relationships of the phasic period of interdigestive migrating contraction to gastrointestinal (GI) transit of drugs and their oral absorption were investigated in mongrel dogs by simultaneous oral dosing of acetaminophen (AAP) and salicylazosulfapyridine (SASP) at the starting points of the phase I and phase III periods of gastric contractions. Strain-gauge force transducers were surgically sutured onto the serosa of the GI tracts in the dogs to measure the interdigestive migrating contractions. The mean absorption time of AAP and the time for the first appearance of sulfapyridine (a bacterial metabolite of SASP in the colon) in plasma were used as the indices of gastric emptying time (GET) and small intestinal transit time (SITT), respectively. In individual dogs, the GET and the SITT at phase I showed a clear delay in comparison with those at phase III. For AAP used as a marker compound here, the systemic bioavailability after oral dosing to intact beagle dogs at doses of 3, 10, and 20 mg/kg was about 55, 63, and 79%, suggesting that AAP undergoes a non-linear hepatic clearance. At a dose of AAP 20 mg/kg, the systemic bioavailability of AAP was 100% in the case of dosing at phase III, but was reduced by half when dosing at phase I. These results indicate that, in oral dosing, the transit of drugs through the GI tract was clearly affected by the phases of gastric contractions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596997     DOI: 10.1023/a:1016270417009

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Inhibition of gastric emptying and drug absorption by narcotic analgesics.

Authors:  W S Nimmo; R C Heading; J Wilson; P Tothill; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

2.  [Gastrointestinal absorption of nitrofurantoin: evaluation of a newly developed method for determination of the gastrointestinal transit time in dogs].

Authors:  H Mizuta; Y Kawazoe; Y Ikeda; K Ogawa
Journal:  Yakugaku Zasshi       Date:  1991-12       Impact factor: 0.302

3.  [Determination of small intestinal transit time in beagle dogs using salicylazosulfapyridine].

Authors:  H Mizuta; Y Kawazoe; K Haga; K Ogawa; T Yokobe
Journal:  Yakugaku Zasshi       Date:  1989-10       Impact factor: 0.302

4.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

5.  Mechanism of propagation of intestinal interdigestive myoelectric complex.

Authors:  G M Carlson; B S Bedi; C F Code
Journal:  Am J Physiol       Date:  1972-04

6.  Kinetics of acetaminophen absorption and gastric emptying in man.

Authors:  J A Clements; R C Heading; W S Nimmo; L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

7.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

8.  Characteristic motor activity of the gastrointestinal tract in fasted conscious dogs measured by implanted force transducers.

Authors:  Z Itoh; S Takeuchi; I Aizawa; R Takayanagi
Journal:  Am J Dig Dis       Date:  1978-03

9.  Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog.

Authors:  H Mizuta; Y Kawazoe; K Ogawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-10       Impact factor: 1.645

10.  Gastrointestinal physiology-regulated dogs: utilization of a bioavailability study of a new thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an antagonist of platelet-activating factor, and its preparations.

Authors:  K Sagara; I Yamada; Y Kawazoe; H Mizuta; M Shibata
Journal:  Biol Pharm Bull       Date:  1994-01       Impact factor: 2.233

View more
  1 in total

1.  Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.

Authors:  Mark G Papich; Marilyn N Martinez
Journal:  AAPS J       Date:  2015-04-29       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.